Summary. In human neutrophil monolayer assays the percentage phagocytosis of Candida krusei by neutrophils was found to be significantly lower (9%) than that for C. albicans (37 "/O). Both organisms required opsonisation with complement products for ingestion. The number of competent neutrophils phagocytosing C. krusei was increased with : antisera specific to C. albicans (49 %) ; the neutrophil chemo-attractant formyl-methionyl-leucylphenylalanine (fmlp) (49 YO); mannan extracted from the cell wall of C. albicans (72 YO); and a crude cell extract from C. krusei (61 %). In the case of C. albicans all but one of these methods increased the proportion of phagocytosing neutrophils per slide. The data provide evidence for differences in quantitative phagocytosis of C. krusei and C. albicans and suggest that C. krusei is resistant to phagocytosis in vitro.
Introduction
Candida krusei is emerging as a common commensal of the mouth, throat and urinary tract.l It is also an emerging pathogen amongst immunologically incompetent hosts.' It is seen in AIDS, cancer treatment, steroid use, drug abuse and primary immunodeficiencies. All involve neutropenia which can result in widespread candidosis.
The emergence of C. krusei as a pathogen in both competent and compromised hosts has increased over the past three decades.l This could be due to the increase in the population of immunocompromised hosts, which has allowed the development of a reservoir of C. krusei, in conjunction with the resistance of C. krusei to antifungal agents. Since the newer azole antifungal agents, fluconazole and itraconazole, are currently used for prophylaxis in cancer patients, it is possible that C. krusei superinfections may emerge.
Protection against systemic candida infections is mainly attributed to neutrophils. Although a major role for neutrophils in normal (non-specific) host defence against C. albicans has been firmly established, little is known about the interaction between C. krusei and neutrophils. Neutrophils undoubtedly play a vital role in host defence against C. krusei. The shorter survival and higher fungal burden noted in immunosuppressed animals suggest a potential role for neutrophils and macrophages as defence mechanisms for disseminated C. krusei infection.2 This implicates any factor which could potentially modulate phagocytosis of C. krusei by neutrophils in vivo. Based on previous s t u d i e~,~,~ there appears to be some correlation between the capacity of Candida spp. to oppose phagocytic killing in vitro and virulence in experimental models but the difference between pathogenic and non-pathogenic species becomes significant only when the rate of killing and the spectrum of active effectors are considered. Several studies have shown that the cell wall of C. krusei differs from that of C. albicans. For example, the glucan content of C. krusei increases on administration of a bis-triazole and the expression of an iC3b receptor is less than that found on C. albican~.~ These differences suggest differences in their interaction with host cells.
Materials and methods

Organ isms
Six clinical isolates of C. krusei were obtained from the National Collection of Pathogenic Fungi, PHLS Mycology Reference Laboratory, Bristol. C. albicans and Saccharomyces cerevisiae were obtained from the Regional Mycology Reference Laboratory, Glasgow. Subcultures and further growth of the organisms was on glucose peptone chloramphenicol agar (GPC) at 37°C.
All cultures were 3-4 days old when used in the neutrophil assays. emulsified in 10 ml of distilled water to give a single cell suspension of blastoconidia. The cell suspension was then diluted to 1 x lo5 cells/ml in Hanks's Balanced Salts Solution (HBSS).
Opsonin
Unpurified isologous serum complement as a component of peripheral blood was used as an opsonin where indicated. Serum was stored at -70°C.
Heut inactivation of C. krusei blastoconidia
Yeast cells were emulsified in 10 ml of distilled water, and then held in a boiling water bath for 20 min.
An tisera
Serum from a histopathologically proven case of systemic candidosis was used as a source of specific anti-C. albicans immunoglobulin. Inactivation of complement was achieved by heating the serum at 56°C for 30 min.
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Fmlp (Sigma) was diluted lop2 M in DMSO and stored at -70°C. This stock solution was then diluted in HBSS to the desired concentration for each set of experimental conditions.
Mannan
Purified cell-wall mannan of C. albicans was obtained as a component of the Pastorex Candida latex agglutination kit (Diagnostics Pasteur, Marnesla-Coquette, France).
Cell-wall extract
A heavy suspension (1 O9 cells/ml) of blastoconidia of C. krusei in 10 ml of distilled water was sonicated for 30 min in a water bath. The cell suspension was assessed microscopically to determine the degree of cell lysis. The supernate from centrifugation of the suspension constituted a crude extract of cell-surface antigen.
Preparation of neutrophil monolayers
Monolayers of glass-adherent neutrophils were prepared as described previously.6 Briefly, drops of blood from finger-tip punctures (single donor throughout) were placed on 16-mm diameter coverglasses. The blood drops were incubated for 30min at 37°C in a humidified chamber. They were then immersed in saline 0.85% w/v (37°C) and agitated to remove the adherent red cells. The coverglasses were then washed again in saline, resulting in confluent neutrophil monolayers.
Assessment of phagocytosis
Neutrophil monolayers were placed in the wells of " Repli" (Sterilin) tissue culture plates containing 1 ml of a 1 x lo5 ml conidial suspension. Normal human serum (100 pl) was added to each monolayer immediately before incubation at 37°C for 30 min. The monolayers were then washed twice in saline 0.85% and inverted over glass cavity slides. Monolayers were examined within 5 min by high power ( x 100 objective) oil immersion microscopy. Ten randomly selected fields of view were examined; the only constraint was that at least two neutrophils be present in each field. The total number of neutrophils/field was counted and the number of conidia ingested by each neutrophil was recorded. From these observations, the following parameters were calculated : percentage phagocytosis (number of neutrophils with one or more ingested conidia/total neutrophil number), and phagocytic index (number of ingested conidia/ neutrophil number containing one or more conidia).
Pre-treatment of neutrophils
Before the addition of conidia, neutrophil monolayers were immersed in either HBSS alone, or fmlp and HBSS, and incubated for 20min at 37°C. Monolayers were then washed to remove excess fmlp before transfer to conidial suspensions. Pre-treatment with mannan was performed in a similar manner.
Statistical analysis
All data were analysed by Student's t test. As replicate experiments were performed on different days and at different times of day, the test results were compared against the control values obtained at the same time. The pooled variance and statistical significance for all control and test values were also calculated to overcome the problem of day to day variability .
Results
Phagocy tosis
The percentage phagocytosis of C. krusei blastoconidia was compared to that of C. albieans and S. cerevisiae. C. krusei was ingested by 7 SD 1.9% of the neutrophils observed. This was in contrast to C. albicans (37 SD 5.1; p < 0.001) and S. cerevisiae (28 SD 6.3 YO ; p < 0.001)). Ingestion of C. krusei did not approach that of C. albicans after 90min. Maximal phagocytosis was seen after 60 min, but this was not significantly different from the phagocytosis seen at 30 min. The ability of C. krusei to evade ingestion was not dependent on metabolic activity. Heat-killed blastoconidia were not phagocytosed significantly compared to viable cells (p > 0.1) (fig. 1) . Phagocytosis was not strain dependent. All six strains were able to resist ingestion (p > 0.1) ( fig. 2) . Ingestion of all strains of C. krusei was significantly lower than that seen for C. albicans (p < 0.001).
Upregulation of phagocytosis by specific anti-C. alb icans immunoglobulin
When anti-C. albicans immunoglobulin was added to the neutrophil assay in addition to serum complement, there was a significant increase in ingestion of C. krusei blastoconidia (p < 0.001). Phagocytosis in the presence of complement-inactivated specific antiserum was not significantly different from that seen with antiserum containing complement.
Maximal ingestion was seen when antiserum and serum complement were added contemporaneously to blastoconidia in the neutrophil assay. There was no significant difference between C. krusei and C. albicans ( fig. 3 ). The antiserum was tested for cross reactivity between the two Candida strains by running absorbed sera after the addition of blastoconidia for 3 h on counterimmuno-electrophoresis gels. Antibodies specific to C. albicans were present as they were absorbed by C. albicans blastoconidia. Blastoconidia of C. krusei did not remove anti-C. albicans immunoglobulin.
Activation of neutrophils with fmlp
Pre-exposing neutrophil monolayers to fmlp increased ingestion of C. krusei from 21 to 49 YO. The level of ingestion in the presence of complement and anti-C. albicans immunoglobulin was 48 % (fig. 4) .
However fmlp + anti-C. albicans immunoglobulin, and complement + fmlp were not significantly different.
Mannan as a stimulator of phagocytosis
Phagocytosis of C. krusei was increased significantly when soluble mannan was added at the same time in the neutrophil assay. This was a dose-dependent phenomenon ( fig. 5 ). Pre-exposure of neutrophils to mannan had no significant effect on ingestion (p > 0.1).
Cell-surface extract of C. krusei as a stimulator of ingestion
An increase in ingestion of C. krusei blastoconidia from 22 to 43 O/ O was seen when the crude cell extract was added to the assay (p < 0.001). The extract alone did not replace the activity of serum complement (p > 0.1) but when extract and complement were added contemporaneously, ingestion was potentiated (p < 0.001).
Discussion
C. krusei is an uncommon but increasingly recognised cause of disseminated fungal infection in immunocompromised patients.l The host defence mechanisms against the organism are not well understood.
Differences in size and cell-wall architecture suggested that there may be differences between C. albicans and C. krusei in their interaction with human neutrophils. The typical morphology of C. krusei is predominantly cylindrical compared with the considerably smaller spherical or oval shape of C. albicans. The size of most blastoconidia of C. krusei is (3-5) x (6-20) pm. Phagocytosis of all strains examined was lower than that seen for C. albicans or S. cereuisiae. However, the inability of neutrophils to ingest C. krusei was not entirely dependent on cell size or morphology, as many of the yeast cells in the Saccharomyces cell population were larger than C. krusei cells.
Fungal surface carbohydrates have been implicated most often as recognition sites for phagocytes.' However, the indirect nature of the evidence which is based on competitive inhibition of phagocytosis by defined molecules dictates caution in the interpretation of results. The possibility of cell-surface antigens of C. krusei conferring protection against phagocytosis was investigated by heat inactivating blastoconidia before exposure to neutrophils. The low level of ingestion was not enhanced. It is apparent that C. krusei does not have a level of metabolic activity which hinders binding to neutrophil surfaces or phagocytosis. It is likely that most of the polysaccharide moiety on the cell surface was destroyed by this process, but it is evident that the cell wall was not made more antigenic through heat inactivation. Human monocyte receptors for B-glucan have been linked to phagocytosis of heat killed blastoconidia, perhaps recognising a heptoglucoside thought to mediate zymosan particle inge~tion.~ However, monocytes may not utilise identical receptors in the recognition of live and boiled or fixed C. albicans blastoconidia. Others suggest the involvement of macrophage mannose receptors in the phagocytosis of C. albicans, but the purity of inhibitory "mannans" is not well documented in many studies.' Mannan is bound to neutrophils by mannan-binding proteins8 This binding has been shown to upregulate phagocytosis but not intracellular killing by neutrophika In the present study, mannan was not active if it was preincubated with neutrophils, suggesting that any effect contributed by this sugar was in collaboration with serum complement. Furthermore, all monoclonal antibodies devised so far against a C. albicans mannan are not cross-reactive with C. kr~sei.~*'-'l Specific effects of opsonins on phagocytosis and triggering of subsequent responses depend on the particular fungal and phagocytic cell type. Potential opsonins may or may not be deposited on cell walls in configurations or at sites that facilitate recognition by phagocyte receptors. Opsonin deposition may supplement or mask fungal loci that stimulate phagocytosis, sometimes changing the receptors that initiate phagocyte activation.
The presence of specific anti-C. albicans immunoglobulin enhanced ingestion of C. krusei two-fold. This did not appear to be due to an increased level of complement in the assay, but was dependent on complement being present. However, specific antibody did not appear to bind to C. krusei, as shown by the absorption studies. Nevertheless, the increase in ingestion would suggest that there was some crossreactivity between the cell surface antigens of C. albicans and C. krusei. Alternatively, the affinity of anti-C. albicans serum for C. krusei was only sufficient to activate the complement cascade thereby stimulating more neutrophils but not increasing the number of internalised yeast cells per neutrophil.
Various host factors can modulate phagocyte responses. Neutrophil activity against a broad array of fungal pathogens can be augmented by cytokines and chemo-attractants. The bacterial chemo-attractant fmlp is very effective in activating neutrophils. In neutrophil monolayer assays fmlp has been shown to enhance phagocytosis of Aspergillus fumigatus12 and C. a l b i~a n s~~ by human neutrophils. For C. krusei the evidence is just as clear; fmlp increased the percentage phagocytosis to levels similar to C. albicans. The synergy between fmlp and anti-C. albicans immunoglobulin suggests that complement was activated even further.
The mechanism of inhibition of phagocytosis of C. krusei is not known and the specific mechanism by which C. krusei evades ingestion has not been established. Several hypotheses can be put forward. Firstly, C. krusei may be a poor activator of complement. In the presence of complement alone C. krusei was not susceptible to phagocytosis. This contention is
